-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Amylyx Pharmaceuticals, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2021 to 2023.
- Amylyx Pharmaceuticals, Inc. Nonoperating Income (Expense) for the quarter ending September 30, 2024 was $2.96M, a 19.9% decline year-over-year.
- Amylyx Pharmaceuticals, Inc. Nonoperating Income (Expense) for the twelve months ending September 30, 2024 was $14.7M, a 9.26% increase year-over-year.
- Amylyx Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2023 was $15.5M, a 314% increase from 2022.
- Amylyx Pharmaceuticals, Inc. annual Nonoperating Income (Expense) for 2022 was $3.74M.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)